Karyopharm Therapeutics Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2020 | $-2.72 | $-6.03 |
| FY2021 | $-1.65 | $-4.79 |
| FY2022 | $-2.02 | $-3.78 |
| FY2023 | $-18.79 | $-4.96 |
| FY2024 | $-14.00 | $-6.04 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2020 | $-2.72 | $-6.03 |
| FY2021 | $-1.65 | $-4.79 |
| FY2022 | $-2.02 | $-3.78 |
| FY2023 | $-18.79 | $-4.96 |
| FY2024 | $-14.00 | $-6.04 |